Company Curative Biotechnology, Inc. Other OTC
Equities
CTYX
US20786Q2093
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11/21/11 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Ron Bordens
PRN | Corporate Officer/Principal | - | 11/21/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12/22/12 |
Theresa Heah
BRD | Director/Board Member | 46 | 31/03 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Paul M. Michael
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 227,000 | 0 | 0 | 99.94 % |
Stock B | 1 | 903,263,385 | 902,756,978 ( 99.94 %) | 0 | |
Stock C | 0 | 30,000,000 | 0 | 0 |
Company contact information
Curative Biotechnology, Inc.
3801 PGA Boulevard Suite 600
33410, Palm Beach Gardens
+
http://www.curativebiotech.comSector
1st Jan change | Capi. | |
---|---|---|
+41.96% | 5.4TCr | |
+45.43% | 4.2TCr | |
-1.57% | 4.19TCr | |
-7.20% | 2.84TCr | |
+11.64% | 2.64TCr | |
-21.61% | 1.9TCr | |
+7.00% | 1.3TCr | |
+28.87% | 1.23TCr | |
+24.81% | 1.22TCr |